Friday 6 November 2026
Export INSP’s income statement to Excel — free account
Inspire Medical Systems, Inc.
INSP Healthcare Medical Devices
Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024.
- Revenue
- −7.93%
- EPS
- −348.0%
- Free cash flow
- −33.1%
Quarter to September 2026, against a year earlier
63.84
2.69
−4.04%
Follow INSP
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 7 | 8 | 8 |
| 19.77% | 18.37% | 17.96% | 13.49% | ||
| 16.95% | 15.97% | 15.63% | 11.44% | ||
ROIC |
6.73% | 6.31% | 6.70% | 1.97% | |
Return on Tangible Assets |
24.84% | 22.68% | 21.04% | 16.35% | |
Average Days of Receivables |
47.90 | 41.91 | 41.97 | 43.38 | |
Free Cash Flow per Share |
2.67 | 3.37 | 4.06 | 3.38 | |
Free Cash Flow |
78.48 | 96.71 | 117.09 | 97.89 | |
Capital Expenditures |
(38.50) | (39.82) | (39.98) | (37.08) | |
| Other line items | |||||
Cash ROIC |
7.20% | 8.99% | 10.21% | 8.48% | |
Accounts Receivable Turnover |
8.57 | 9.26 | 7.46 | 8.28 | |
Accounts Payable Turnover |
3.54 | 3.67 | 3.11 | 2.50 | |
Inventory Turnover |
1.18 | 0.98 | 0.85 | 0.76 | |
Average Days of Payables |
100.18 | 117.33 | 79.37 | 114.19 | |
Days of Inventory on Hand |
398.06 | 466.07 | 499.17 | 536.73 | |
Tax Rate |
1.21 | 1.05 | 0.95 | 2.27 | |
Research and Development Expense of Revenue |
11.31% | 11.06% | 11.09% | 11.08% | |
Selling, General and Administrative Expense of Revenue |
68.49% | 69.11% | 69.02% | 73.31% | |
Share Based Compensation of Revenue |
14.28% | 14.19% | 13.28% | 13.26% | |
Interest Coverage |
9.04 | — | — | — | |
Operating CF/Net income |
0.80 | 1.04 | 1.16 | 1.34 | |
Depreciation/Fixed assets |
0.11 | 0.14 | 0.15 | 0.20 | |
Capex/Depreciation |
(3.48) | (2.83) | (2.51) | (2.13) | |
Revenue per Share |
31.05 | 31.89 | 31.17 | 30.45 | |
Operating CF per Share |
3.98 | 4.76 | 5.45 | 4.67 | |
Capex per Share |
(1.31) | (1.39) | (1.39) | (1.28) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 5 Nov 2026